Jennifer Rogers

What we know so far about the Oxford vaccine

(Photo by JOEL SAGET/AFP via Getty Images)
  • Comments

It’s three for three as far as positive outcomes from Covid vaccine trials are concerned. But the announcement from AstraZeneca and Oxford University, at a first glance, may not seem to be as exciting as those from Pfizer-BioNTech and Moderna. The figures are a bit of a head-scratcher, so let’s look at them in more detail.

Already a subscriber? Log in

Keep reading with a free trial

Subscribe and get your first month of online and app access for free. After that it’s just £1 a week.

There’s no commitment, you can cancel any time.

Or

Unlock more articles

REGISTER

Read next

Trending

Edward Howell

Why Kim Jong-un keeps crying

Crying in public is something we tend to associate with the North Korean people rather than their rulers ­– who are often described as having a near god-like status. Who can forget, following the death of Kim Jong-il in 2011, how the streets of Pyongyang were lined with weeping mourners? So perhaps it was surprising to

Because you read about coronavirus

Latest

Comments

Don't miss out

Join the conversation with other Spectator readers. Subscribe to leave a comment.

Already a subscriber? Log in